TY - JOUR
T1 - Clinical Pathway for the Diagnosis and Management of Patients With Relapsing–Remitting Multiple Sclerosis
T2 - A First Proposal for the Peruvian Population
AU - Caparó-Zamalloa, César
AU - Velásquez-Rimachi, Victor
AU - Mori, Nicanor
AU - Dueñas-Pacheco, Wenzel Ivan
AU - Huerta-Rosario, Andrely
AU - Farroñay-García, Chandel
AU - Molina, Roberto A.
AU - Alva-Díaz, Carlos
N1 - Publisher Copyright:
Copyright © 2021 Caparó-Zamalloa, Velásquez-Rimachi, Mori, Dueñas-Pacheco, Huerta-Rosario, Farroñay-García, Molina and Alva-Díaz.
PY - 2021/10/21
Y1 - 2021/10/21
N2 - Background: Relapsing–remitting multiple sclerosis (RRMS) is a subtype of degenerative inflammatory demyelinating disease of multifactorial origin that affects the central nervous system and leads to multifocal neurological impairment. Objectives: To develop a clinical pathway (CP) for the management of Peruvian patients with RRMS. Methods: First, we performed a literature review using Medline, Embase, Cochrane, ProQuest, and Science direct. Then, we structured the information as an ordered and logical series of five topics in a defined timeline: (1) How should MS be diagnosed? (2) How should a relapse be treated? (3) How should a DMT be initiated? (4) How should each DMT be used? and (5) How should the patients be followed? Results: The personnel involved in the care of patients with RRMS can use a series of flowcharts and diagrams that summarize the topics in paper or electronic format. Conclusions: We propose the first CP for RRMS in Peru that shows the essential steps for diagnosing, treating, and monitoring RRMS patients based on an evidence-based medicine method and local expert opinions. This CP will allow directing relevant clinical actions to strengthen the multidisciplinary management of RRMS in Peru.
AB - Background: Relapsing–remitting multiple sclerosis (RRMS) is a subtype of degenerative inflammatory demyelinating disease of multifactorial origin that affects the central nervous system and leads to multifocal neurological impairment. Objectives: To develop a clinical pathway (CP) for the management of Peruvian patients with RRMS. Methods: First, we performed a literature review using Medline, Embase, Cochrane, ProQuest, and Science direct. Then, we structured the information as an ordered and logical series of five topics in a defined timeline: (1) How should MS be diagnosed? (2) How should a relapse be treated? (3) How should a DMT be initiated? (4) How should each DMT be used? and (5) How should the patients be followed? Results: The personnel involved in the care of patients with RRMS can use a series of flowcharts and diagrams that summarize the topics in paper or electronic format. Conclusions: We propose the first CP for RRMS in Peru that shows the essential steps for diagnosing, treating, and monitoring RRMS patients based on an evidence-based medicine method and local expert opinions. This CP will allow directing relevant clinical actions to strengthen the multidisciplinary management of RRMS in Peru.
KW - Peru
KW - critical pathways
KW - multiple sclerosis
KW - patient care management
KW - relapsing-remitting
UR - http://www.scopus.com/inward/record.url?scp=85118653057&partnerID=8YFLogxK
U2 - 10.3389/fneur.2021.667398
DO - 10.3389/fneur.2021.667398
M3 - Artículo de revisión
AN - SCOPUS:85118653057
SN - 1664-2295
VL - 12
JO - Frontiers in Neurology
JF - Frontiers in Neurology
M1 - 667398
ER -